Intraoral Scanner Assessment of Maxillary Marginal Soft Tissue Volume Change After Non-Surgical Periodontal Therapy in Type 2 Diabetes
Evaluation of Marginal Soft Tissue Volume Changes in the Maxilla After Non-Surgical Periodontal Therapy Using an Intraoral Scanner and Their Relationship With Type 2 Diabetes Mellitus: A Prospective Observational Cohort Study
Gum treatment (non-surgical periodontal therapy, also called scaling and root planing) reduces swelling in the gums. As the swelling goes down, the gum tissue around the teeth can shrink. This change is hard to measure with routine dental examinations. This study uses a 3D intraoral scanner, which takes digital images of the mouth without X-rays, to measure how much the gum tissue of the upper jaw changes in volume after treatment.
The study also asks whether this change is different in people with type 2 diabetes compared with people without diabetes. Diabetes can slow healing and change the body's inflammatory response, but its effect on gum volume after periodontal treatment has not been measured in three dimensions before.
Adults with stage III periodontitis who attend the Periodontology clinic at Afyonkarahisar Health Sciences University, Faculty of Dentistry, are invited to take part. Participants receive their routine gum treatment, which is not changed because of the study. Their upper jaw is scanned with an intraoral scanner before treatment and again at the routine 3-month check-up. The two scans are overlaid on a computer, and the change in gum volume is calculated. Researchers then compare people with and without type 2 diabetes.
Diabetes status and HbA1c values are taken from existing health records. The study does not require extra blood tests, X-rays, or extra visits.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Adults with generalized stage III periodontitis attending the Periodontology clinic of Afyonkarahisar Health Sciences University, Faculty of Dentistry, who need routine non-surgical periodontal therapy. Participants are classified by existing health records as having type 2 diabetes or being systemically healthy.
Description
Inclusion Criteria:
Adults aged 18 years or older who provide written informed consent
- Generalized stage III periodontitis (2017 World Workshop classification)
- All maxillary teeth present (third molars excluded)
- Tooth mobility of Miller grade 0 or 1
- Type 2 diabetes group: type 2 diabetes mellitus diagnosis confirmed from existing health records
- Non-diabetic group: systemically healthy, with an existing HbA1c below 5.7%
Exclusion Criteria:
- Stage IV periodontitis
- Any tooth with Miller mobility grade 2 or 3 in the study area
- Current smoking or heavy past smoking (10 pack-years or more)
- Periodontal treatment or antibiotic use within the previous 6 months
- Pregnancy or lactation
- Medication causing gingival enlargement (e.g., phenytoin, cyclosporine, calcium channel blockers) or immunosuppressive therapy
- Systemic disease other than diabetes that affects the periodontium
- Extensive restorations, fixed prostheses, or implants in the maxillary teeth
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Type 2 Diabetes With Stage III Periodontitis
Adults with type 2 diabetes mellitus (diagnosis confirmed from existing health records) and generalized stage III periodontitis who receive routine non-surgical periodontal therapy at the Periodontology clinic. The treatment is not altered for the study. The upper jaw is scanned with an intraoral scanner before treatment and at the routine 3-month check-up. |
|
No Diabetes With Stage III Periodontitis
Systemically healthy adults without diabetes (confirmed from existing health records) with generalized stage III periodontitis who receive routine non-surgical periodontal therapy at the Periodontology clinic. The treatment is not altered for the study. The upper jaw is scanned with an intraoral scanner before treatment and at the routine 3-month check-up. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Buccal Marginal Gingival Soft Tissue Volume of the Maxilla
Time Frame: Baseline (before treatment) to 3 months after non-surgical periodontal therapy
|
Volume change (mm3) of the buccal marginal gingival tissue of the maxillary arch, measured on superimposed 3D intraoral scans. Scans are overlaid on the tooth crown surfaces and the volume between baseline and 3-month surfaces is calculated within a region of interest bounded coronally by the gingival margin and apically by the mucogingival junction. |
Baseline (before treatment) to 3 months after non-surgical periodontal therapy
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Decision No. 2026/605
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.